Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
BIOMARKER:
CCNE1 amplification
i
Other names:
CCNE1, CCNE, Cyclin E1
Associations
(18)
News
Trials
C2 | Sensitive
C3 | Sensitive
D | Sensitive
C2 | Resistant
C3 | Resistant
D | Resistant
Show legend
Include preclinical:
Drug categories
Cyclin Dependent Kinase Inhibitors
Serine-Threonine Kinase Inhibitors
Epigenetics
CD Protein Inhibitors
Immune Checkpoint Inhibitors
Immunotherapy
BCL Inhibitors
Chemotherapy
Tyrosine Kinase Inhibitors
Cancel
Ovarian Cancer
Solid Tumor
Gastric Cancer
Renal Cell Carcinoma
Breast Cancer
Melanoma
Urothelial Cancer
Hepatocellular Cancer
AZD1775
C3
CCNE1 amplification
|
Ovarian Cancer
|
AZD1775
C2
CCNE1 amplification
|
Solid Tumor
|
AZD1775
D
CCNE1 amplification
|
Melanoma
|
AZD1775
D
CCNE1 amplification
|
Urothelial Cancer
|
AZD1775
RP-6306
C2
CCNE1 amplification
|
Ovarian Cancer
|
RP-6306
C2
CCNE1 amplification
|
Solid Tumor
|
RP-6306
D
CCNE1 amplification
|
Hepatocellular Cancer
|
RP-6306
INX-315
C2
CCNE1 amplification
|
Ovarian Cancer
|
INX-315
D
CCNE1 amplification
|
Gastric Cancer
|
INX-315
BLU-222
C2
CCNE1 amplification
|
Ovarian Cancer
|
BLU-222
ACR-368 + LY3300054
C3
CCNE1 amplification
|
Ovarian Cancer
|
ACR-368 + LY3300054
NBL-001
C3
CCNE1 amplification
|
Ovarian Cancer
|
NBL-001
SNS-032
D
CCNE1 amplification
|
Ovarian Cancer
|
SNS-032
MK-7965
D
CCNE1 amplification
|
Ovarian Cancer
|
MK-7965
axitinib
D
CCNE1 amplification
|
Renal Cell Carcinoma
|
axitinib
APR-1051
D
CCNE1 amplification
|
Ovarian Cancer
|
APR-1051
carboplatin + paclitaxel
C3
CCNE1 amplification
|
Ovarian Cancer
|
carboplatin + paclitaxel
CDK2 inhibitor
D
CCNE1 amplification
|
Breast Cancer
|
CDK2 inhibitor
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
